Re GBM AGILE: primary data readout will be 12 months after the randomisation of the last patient in the paxalisib arm.
This happened around Q2 2022 if I remember correctly.
Add some time on top of that for data cleaning and analysis - that’s when we can expect the data.
Ann: Kazia raises $4.5m and launches share purchase plan, page-23
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)